SA
Sign upLog In
RCEL

RCEL Common Stock Issued

$14.02MTTM · USD

Period ending:

AnnualQuarterlyTTMChart Studio →
RCEL FY Common Stock IssuedUSD
RCEL FY Common Stock Issued1993-12-31: $6.78M1994-12-31: $256.56K1995-12-31: $187.41K1996-12-31: $0.001997-12-31: $0.001998-12-31: $0.001999-12-31: $2.66M2000-12-31: $4.29M2001-12-31: $1.10M2002-12-31: $768.51K2004-06-30: $5.09M2005-06-30: $11.73M2006-06-30: $7.42M2007-06-30: $11.67M2008-06-30: $2.83K2009-06-30: $0.002010-06-30: $1.68M2011-06-30: $13.37M2012-06-30: $0.002013-06-30: $9.48M2014-06-30: $0.002015-06-30: $4.74M2016-06-30: $9.13M2017-06-30: $8.41M2018-06-30: $22.78M2019-06-30: $42.25M2020-06-30: $81.70M2021-06-30: $69.11M2021-12-31: $0.002022-12-31: $0.002023-12-31: $0.002024-12-31: $0.002025-12-31: $14.14M$81.70M$0.00
1993-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RCEL common stock issued history

Cash received from issuing common stock. The available annual fiscal periods series contains 33 observations from Dec 31, 1993 to Dec 31, 2025.

Avita Medical Inc Common Stock Issued — Annual fiscal periods (USD)
Period endingCommon Stock Issued (USD)
14,141,000
0
0
0
0
69,106,000
81,702,000
42,251,266
22,783,007
8,411,159
9,131,072
4,736,241
0
9,484,501
0
13,373,069
1,679,122
0
2,828
11,674,636
7,424,075
11,733,329
5,087,621
768,511
1,098,435
4,288,940
2,663,581
0
0
0
187,405
256,563
6,775,913

Compare common stock issued

All RCEL financial metrics · RCEL stock overview · How to interpret financial metrics

Explore More

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.